Cercar
05/07/2023
Neuropsychiatric adverse reactions in patients treated with denosumab: two case reports and a review of data from the FDA Adverse Event Reporting System (FAERS)
Oteo-Álvaro Á., García C.G., Sánchez A.I., Santamaria C.A., de Diego-Adeliño J.. Neuropsychiatric adverse reactions in patients treated with denosumab: two case reports and a review of data from the FDA Adverse Event Reporting System (FAERS). OSTEOPOROSIS INTERNATIONAL. 2023; 34(10)DOI:10.1007/s00198-023-06838-z. PMID:37405407. IF:4.200(Q1/3D).
05/07/2023
Psychometric validation of the 15-item Questionnaire about the Process of Recovery in Spain (QPR-15-SP)
Goodman-Casanova J.M., Cuesta-Lozano D., Alupoaei C., Bello, EMG, Herrera-Imbroda J., Mayoral-Cleries F., Guzman-Parra J.. Psychometric validation of the 15-item Questionnaire about the Process of Recovery in Spain (QPR-15-SP). Frontiers in Psychology. 2023; 14DOI:10.3389/fpsyg.2023.1178341. PMID:37484089. IF:2.600(Q2/3D).
01/07/2023
Massive Neonatal Arterial Ischemic Stroke
Arca, G, Nunez, C, Stephan-Otto, C, Arnaez, J, Agut, T, Cordeiro, M, Boronat, N, Lubian-Lopez, S, Benavente-Fernandez, I, Valverde, E, Garcia-Alix, A. Massive Neonatal Arterial Ischemic Stroke. PEDIATRIC NEUROLOGY. 2023; 144DOI:10.1016/j.pediatrneurol.2023.03.013. PMID:37087915. IF:3.200(Q1/2D).
01/07/2023
Exploration of cannabis use and polygenic risk scores on the psychotic symptom progression of a FEP cohort
Segura, AG, Mane, A, Prohens, L, Rodriguez, N, Mezquida, G, Cuesta, MJ, Vieta, E, Amoretti, S, Lobo, A, Gonzalez-Pinto, A, Diaz-Caneja, CM, Bejarano, AR, Jimenez, E, Baeza, I, Legido, T, Saiz-Ruiz, J, Bernardo, M, Mas, S. Exploration of cannabis use and polygenic risk scores on the psychotic symptom progression of a FEP cohort. PSYCHIATRY RESEARCH. 2023; 325DOI:10.1016/j.psychres.2023.115249. PMID:37178502. IF:4.200(Q1/2D).